Skip to main content
. 2018 Nov 21;9(12):1258–1262. doi: 10.1021/acsmedchemlett.8b00422

Table 1. Inhibitor Sequences and Inhibition Constants (Ki).

Inhibitor Sequencea Protease Ki (nM)
MCoTI-II GGVCPKILKKCRRDSDCPGACICRGNGYCGSGSD KLK4 1.6 ± 0.1
    Plasmin 28 ± 631
    Trypsin 0.0023 ± 0.000718
    FXIIa 750 ± 8031
    Other proteasesb >10,000
MC-K6R GGVCPRILKKCRRDSDCPGACICRGNGYCGSGSD KLK4 0.30 ± 0.1
MC-P5Q GGVCQKILKKCRRDSDCPGACICRGNGYCGSGSD KLK4 0.13 ± 0.08
MC-V3F GGFCPKILKKCRRDSDCPGACICRGNGYCGSGSD KLK4 1.3 ± 0.4
MC-FCQR GGFCQRILKKCRRDSDCPGACICRGNGYCGSGSD KLK4 0.10 ± 0.03
    Trypsin 31 ± 3
    FXa 500 ± 10
    Other proteasesc >10,000
MC-FCQR-QK GGFCQRILQQCQQDSDCPGACICKGNGYCGSGSD KLK4 0.44 ± 0.15
    Trypsin 6.9 ± 0.7
    FXa 520 ± 10
    Other proteasesc >10,000
MC-K6R-QK GGVCPRILQQCQQDSDCPGACICKGNGYCGSGSD KLK4 1.8 ± 0.5
a

All peptides have a cyclic backbone with disulfide bonds between C4–C21, C11–C23, and C17–C28. Substituted residues are shown in bold, and Lys residues used for Alexa Fluor 488 labeling are underlined.

b

KLK5, KLK7, KLK14, FXa, thrombin, and plasma kallikrein.

c

KLK5, KLK7, KLK14, plasmin, FXIIa, thrombin, and plasma kallikrein.